Eprosartan: profile and news
Why Solvay dumped Dishman Pharma? Feb 7, 2006
Some of the big drugs that Solvay sources from Dishman includes vitamin D3 intermediates, along with Eprosartan, which is a cardiac drug. ... - Moneycontrol.com,
Why Solvay dumped Dishman Pharma? Feb 7, 2006
Some of the big drugs that Solvay sources from Dishman includes vitamin D3 intermediates, along with Eprosartan, which is a cardiac drug. ... - Moneycontrol.com,
Dishman to expand EM capacity to 7.2mt Jan 12, 2006
Dishman Pharmaceuticals plans to increase installed capacity of its Eprosartan Mesylate (EM) plant from 6. MT to 7.2 MT per month to meet the future demand of ... - Business Standard,
Wyeth’s President, Research & Development, Wyeth Pharmaceuticals ... Dec 9, 2005
...including Dobutamine (Dobutrex) for the acute management of congestive heart failure, Ropinerole (Requip) for Parkinson's Disease, Eprosartan (Teveten) for ... - PharmaLive.com (press release),
SOLVAY and PRONOVA BIOCARE sign license agreement for OMACOR® to Sep 25, 2005
...part of the Solvay Pharmaceuticals' cardiology product portfolio, which also includes the anti-hypertensives, TEVETEN® (eprosartan), PHYSIOTENS® (moxonidine ... - CompanynewsGroup (Communiqués de presse),
SOLVAY and PRONOVA BIOCARE sign license agreement for OMACOR(R) to ... Sep 26, 2005
OMACOR(R) is part of the Solvay Pharmaceuticals' cardiology product portfolio, which also includes the anti-hypertensives, TEVETEN(R) (eprosartan), PHYSIOTENS(R ... - Invest Valley,
Preliminary Studies Suggest Potential Metabolic Effects of ... Sep 7, 2005
...of a study of 119 patients with type 2 diabetes and mildly raised blood pressure that compared the metabolic effects of Micardis® and another ARB, eprosartan. ... - PharmaLive.com (press release),
Potential metabolic effects of telmisartan in preliminary studies Sep 7, 2005
9 Derosa G, Ragonesi PD, Mugellini A, Ciccarelli L, Fogari R. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and ... - RxPG NEWS,
Which blood pressure drug is best after a stroke? Aug 12, 2005
...strokes. But the results of this new study showed that the angiotensin receptor blocker, eprosartan, was even more effective. Patients ... - Macleans,
UPDATE 1-Kos Pharma profit better than expected, sales jump Aug 4, 2005
Revenue growth was helped by contributions from three recently acquired blood pressure treatments: Teveten (eprosartan), Teveten HCT (eprosartan and ... - Reuters
TRICARE Moves Three Medications to Non-Formulary Status Jul 30, 2005
Teveten® (or “eprosartan�) and Teveten HCT® (or “eprosartan with hydrochlorothiazide�), both of which are used to treat high blood pressure. ... - Navy Compass
Attention Health and Lifestyle Editors: Jun 2, 2005
...cerebrovascular events in hypertensive stroke survivors between two anti-hypertensive therapies, the angiotensin receptor blocker (ARB) eprosartan (Teveten(R ... - Canada NewsWire (press release),
TRICARE Moves Medications to Non-Formulary Status Apr 22, 2005
...formulary category of its new Formulary: Nexium® (esomeprazole), a medication for ulcers and other stomach problems, and Teveten® (eprosartan) and Teveten HCT ... - Gulf1,
Highlights of the 30th International Stroke Conference CME Mar 1, 2005
Diener presented the initial results of the Morbidity and Mortality After Stroke - Eprosartan vs Nitrendipine for Secondary Prevention (MOSES) trial, a ... - Medscape (subscription)
Biovail Reports Fourth Quarter, Year-End 2004 Financial Results Mar 10, 2005
In addition, development efforts continue for novel formulations of several products, including venlafaxine, bupropion, zolpidem, eprosartan, enalapril, and ... - Business Wire (press release),
